待处理
入排:排除
图源:待检查
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial.
Matteo Rosellini, Elisa Tassinari, Andrea Marchetti, Veronica Mollica, Francesco Massari
Eur Urol 85(1) 97-98
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板